Status: Recruiting
SEEG-Guided DBS for OCD
This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open-label stimulation for an additional 6 months. The study will be conducted in 3 stages: Stage 1 will consist of SEEG brain mapping and optimization of stimulation parameters. Stage 2 will consist of DBS surgery and further optimization of stimulation parameters. Stage 3 will be randomized, crossover treatment, followed by open-label treatment.
Participants needed: 12
Trial details
Age: 22-75Biological sex: AllType: InterventionalSponsor: Casey H. Halpern, M.D.Updated: May 14, 2026Locations: 2
Eligibility criteria
≥ 22 years and ≤ 75 years of age, at the time of screening [+22]
Diagnosis of, according to the Mini International Neuropsychiatric Interview (MI... [+24]